Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in Western countries, accounting for 20–30% of general population and reaching a prevalence of 55% in patients with type 2 diabetes mellitus (T2DM). Insulin resistance plays a key role in pathogenic mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales: Tacelli, Matteo, Celsa, Ciro, Magro, Bianca, Giannetti, Aurora, Pennisi, Grazia, Spatola, Federica, Petta, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316860/
https://www.ncbi.nlm.nih.gov/pubmed/30413050
http://dx.doi.org/10.3390/ph11040121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6316860/
https://www.ncbi.nlm.nih.gov/pubmed/30413050
http://dx.doi.org/10.3390/ph11040121

Ejemplares similares